Genetic Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GENE and other ETFs, options, and stocks.

About GENE

Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments. 

CEO
Simon Morriss
CEOSimon Morriss
Employees
60
Employees60
Headquarters
Fitzroy, Victoria (VIC)
HeadquartersFitzroy, Victoria (VIC)
Founded
1987
Founded1987
Employees
60
Employees60

GENE Key Statistics

Market cap
10.53M
Market cap10.53M
Price-Earnings ratio
-0.08
Price-Earnings ratio-0.08
Dividend yield
Dividend yield
Average volume
25.05K
Average volume25.05K
High today
$2.37
High today$2.37
Low today
$2.23
Low today$2.23
Open price
$2.35
Open price$2.35
Volume
27.36K
Volume27.36K
52 Week high
$5.90
52 Week high$5.90
52 Week low
$1.80
52 Week low$1.80

GENE News

TipRanks 4d
Genetic Technologies Reports Robust Growth and Expansion

Genetic Technologies (GENE) has released an update. Genetic Technologies Limited has reported significant growth with a 500% increase in commercial samples for...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.